Trial With Telomerase Peptide Vaccine In Combination With Temozolomide in Patients With Advanced Malignant Melanoma
Clinical trial NCT01247623 · COMPLETED
Trial details
- NCT number
- NCT01247623
- Sponsor
- Oslo University Hospital
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Primary completion
- 2011-09-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.